Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Reference18 articles.
1. Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States.;Barua;Ann Intern Med,2015
2. Limited access to new hepatitis C virus treatment under state medicaid programslimited access to new HCV treatment.;Canary;Ann Intern Med,2015
3. Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.;Gimeno-Ballester;Expert Rev Gastroenterol Hepatol,2016
4. A cost utility analysis of simeprevir used with peginterferonribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service.;Westerhout;J Med Econ,2015
5. 3rd, Gowda C, Urick PN et al. Disparities in absolute denial of modern Hepatitis C therapy by type of insurance.;Lo Re;Clin Gastroenterol Hepatol,2016
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty;The Journal of Arthroplasty;2024-07
2. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions;The Lancet Gastroenterology & Hepatology;2024-04
3. Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden;Harm Reduction Journal;2023-06-12
4. Disparities in hepatocellular carcinoma survival by Medicaid-status: A national population-based risk analysis;European Journal of Surgical Oncology;2023-04
5. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016–2019;Clinical Infectious Diseases;2023-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3